QURE: uniQure N.V

QURE新闻

• 18:52 uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix
• 18:28 Is QURE Stock Attractive After Its Rally, Rich Valuation, and Hold?
• 18:25 QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway
• 14:15 3 Biotech Stocks to Watch Before Wall Street Catches On
• 13:55 uniQure (QURE) Now Trades Above Golden Cross: Time to Buy?
• 12:45 Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing
• 21:00 A New All-Time High, an 81% Overnight Gain, and One "Forever Stock"
• 14:29 QURE Announces Initial Data on Gene therapy for Temporal Lobe Epilepsy
• 18:19 QURE Soars as FDA Backs AMT-130 Data for Accelerated Approval
• 12:24 QURE Was Just the Beginning: 5 Biotech Catalysts I'm Watching Now
• 21:15 Dow Jones Futures: Nvidia Leads 5 Chips Near Buy Points; SpaceX Stock Needs This
• 21:15 Dow Jones Futures: U.S.-Iran Talks Begin; Nvidia, SpaceX In Focus With Micron Earnings Ahead
• 19:28 Biohaven: Upgrading To Buy On Protein Degraders Pivotal Study Initiations (BHVN)
• 17:32 uniQure Stock Looks Drastically Undervalued After Upbeat FDA Meeting
• 15:46 Stock Market Rallies On Iran Deal Despite Hawkish Fed; SpaceX Backs Off Highs: Weekly Review
• 13:48 Sarepta: Caution Still Warranted Despite FDA's Gene Therapy Friendly Stance (NASDAQ:SRPT)
• 11:30 uniQure (QURE) Soars 78.4%: Is Further Upside Left in the Stock?
• 20:37 Dow Jones Futures Rise After Fed Rate Hike Bets Hit Stocks; SpaceX Falls As Robinhood Jumps
• 20:35 Stocks Retreat as Fed Signals Possible Higher Interest Rates
• 19:40 uniQure: FDA's Latest Stance On Huntington's BLA Sends Stock Soaring (NASDAQ:QURE)
• 18:12 Biotech Stocks Surge As UniQure 'Nail-Biting Journey' Comes To An End